Characteristics and outcomes of 100 consecutive patients with acute stroke and COVID-19

J Neurol Sci. 2021 Apr 15:423:117348. doi: 10.1016/j.jns.2021.117348. Epub 2021 Feb 17.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Ischemia / complications
  • Brain Ischemia / drug therapy
  • Brain Ischemia / therapy
  • COVID-19 / complications*
  • COVID-19 Testing
  • Comorbidity
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Glasgow Coma Scale
  • Headache / epidemiology
  • Heart Disease Risk Factors
  • Humans
  • Male
  • Mechanical Thrombolysis
  • Middle Aged
  • SARS-CoV-2*
  • Sensation Disorders / epidemiology
  • Stroke / complications*
  • Stroke / drug therapy
  • Stroke / surgery
  • Symptom Assessment
  • Thrombolytic Therapy
  • Time-to-Treatment
  • Tissue Plasminogen Activator / therapeutic use
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator